---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-071814"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2026-06-09T20:01:28+00:00"
generated_at: "2026-06-09T20:02:44.697112+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# German antitrust regulator clears Esperion acquisition by ArchiMed

## Summary
- Bundeskartellamt cleared the merger effective June 2, 2026, as notified June 8.
- Completion still requires HSR waiting period expiration and stockholder approval.
- Special stockholder meeting to vote on merger scheduled for July 8, 2026, at 8:00 a.m. ET.
- Merger announced May 1, 2026; Esperion to become wholly owned by ArchiMed affiliate.

## SEC filing metadata
- accession: 0001104659-26-071814
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2026-06-09T20:01:28+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000110465926071814/0001104659-26-071814-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000110465926071814/tm2617356d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-071814
- JSON: https://secwatch.observer/filing/0001104659-26-071814.json
- Plain text: https://secwatch.observer/filing/0001104659-26-071814.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.